Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies.
Claudio BorghiStefano OmboniGiorgio ReggiardoStefano BacchelliDaniela Degli EspostiEttore Ambrosioninull nullPublished in: Blood pressure (2017)
In cardiac patients of the SMILE studies with arterial hypertension treatment with the ACE-inhibitor zofenopril was beneficial in reducing the 1-year risk of CV events as compared to placebo and ramipril. An efficacy similar to that of zofenopril was observed with lisinopril.
Keyphrases
- acute myocardial infarction
- arterial hypertension
- end stage renal disease
- left ventricular
- ejection fraction
- newly diagnosed
- chronic kidney disease
- blood pressure
- prognostic factors
- randomized controlled trial
- percutaneous coronary intervention
- electronic health record
- angiotensin ii
- heart failure
- acute coronary syndrome
- big data
- angiotensin converting enzyme
- combination therapy
- data analysis